Trial · NCT00281580
Participant flow48
How many started, completed or left each group, period by period.
1 to 20 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Placebo (Pl) | 46 | |
| Overall Study | STARTED | Telmisartan 20 mg (T20) | 42 | |
| Overall Study | STARTED | Telmisartan 40 mg (T40) | 130 | |
| Overall Study | STARTED | Telmisartan 80 mg (T80) | 135 | |
| Overall Study | STARTED | Telmisartan 20 mg Plus Amlodipine 2.5 mg (T20+A2.5) | 44 | |
| Overall Study | STARTED | Telmisartan 20 mg Plus Amlodipine 5 mg (T20+A5) | 46 | |
| Overall Study | STARTED | Telmisartan 20 mg Plus Amlodipine 10 mg (T20+A10) | 44 | |
| Overall Study | STARTED | Telmisartan 40 mg Plus Amlodipine 2.5 mg (T40+A2.5) | 47 | |
| Overall Study | STARTED | Telmisartan 40 mg Plus Amlodipine 5 mg (T40+A5) | 143 | |
| Overall Study | STARTED | Telmisartan 40 mg Plus Amlodipine 10 mg (T40+A10) | 129 | |
| Overall Study | STARTED | Telmisartan 80 mg Plus Amlodipine 2.5 mg (T80+A2.5) | 48 | |
| Overall Study | STARTED | Telmisartan 80 mg Plus Amlodipine 5 mg (T80+A5) | 146 | |
| Overall Study | STARTED | Telmisartan 80 mg Plus Amlodipine 10 mg (T80+A10) | 142 | |
| Overall Study | STARTED | Amlodipine 2.5 mg (A2.5) | 50 | |
| Overall Study | STARTED | Amlodipine 5 mg (A5) | 140 | |
| Overall Study | STARTED | Amlodipine 10 mg (A10) | 129 | |
| Overall Study | COMPLETED | Placebo (Pl) | 39 | |
| Overall Study | COMPLETED | Telmisartan 20 mg (T20) | 41 | |
| Overall Study | COMPLETED | Telmisartan 40 mg (T40) | 125 | |
| Overall Study | COMPLETED | Telmisartan 80 mg (T80) | 118 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00281580/flow